Systolic Blood Pressure and the Risk of Kidney Replacement Therapy and Mortality in Patients with Chronic Kidney Disease Stages 4–5

Systolic Blood Pressure and the Risk of Kidney Replacement Therapy and Mortality in Patients with Chronic Kidney Disease Stages 4–5

Introduction: In patients with chronic kidney disease stages 4 and 5 (CKD stages 4–5) without dialysis and arterial hypertension, it is unknown if the values of systolic blood pressure (SBP) considered in control (<120 mm Hg) are associated with kidney replacement therapy (KRT) and mortality....

Full description

Bibliographic Details
Main Authors: Jonathan S. Chávez-Iñiguez, Jose J. Zaragoza, Jahir R. Camacho-Guerrero, Vanessa Villavicencio-Cerón, Rafael Valdez-Ortiz, Ana E. Huerta-Orozco, Gael Chávez-Alonso, Ana E. Oliva-Martinez, Bladimir Díaz-Villavicencio, Clementina E. Calderón-García, Jose D. González-Barajas, Manuel Arizaga-Nápoles, Frida M. De La Vega-Méndez, Juan A. Gómez-Fregoso, Francisco G. Rodríguez-García, Guillermo Navarro-Blackaller, Ramón Medina-González, Luz Alcantar-Vallin, Guillermo García-García
Format: Article
Language:English
Published: Karger Publishers 2023-08-01
Series:Kidney & Blood Pressure Research
Subjects:
hypertension
kidney replacement therapy
chronic kidney disease
mortality
Online Access:https://beta.karger.com/Article/FullText/533438

Internet

https://beta.karger.com/Article/FullText/533438

Similar Items